Barclays PLC 13D and 13G filings for Oaktree Acquisition Corp. III Life Sciences:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-11 4:06 pm Sale | 2025-12-31 | 13G | OAKTREE ACQUISITION CORP III OACC | Barclays PLC | 861,625 4.350% | -437,500 (-33.68%) | Filing |
| 2025-05-13 5:11 pm Purchase | 2025-03-31 | 13G | OAKTREE ACQUISITION CORP III OACC | Barclays PLC | 1,299,125 7.190% | 1,299,125 (New Position) | Filing |